UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study

Journal of thrombosis and haemostasis, 2022-01, Vol.20 (1), p.92-103

2022

Volltextzugriff (PDF)

A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon

The New England journal of medicine, 2013-12, Vol.369 (24), p.2304-2312

2013

Volltextzugriff (PDF)

Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case‐cohort

Pharmacotherapy, 2024-06, Vol.44 (6), p.416-424

2024

Volltextzugriff (PDF)

Association of VKORC1 polymorphisms and major bleedings in patients who are treated with vitamin K antagonists

Journal of internal medicine, 2023-01, Vol.293 (1), p.124-127

2023

Volltextzugriff (PDF)

Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism

PloS one, 2020-04, Vol.15 (4), p.e0232354

2020

Volltextzugriff (PDF)

Switching from vitamin K antagonists to direct oral anticoagulants in non‐valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?

Journal of thrombosis and haemostasis, 2022-02, Vol.20 (2), p.339-352

2022

Volltextzugriff (PDF)

The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment

PloS one, 2015-04, Vol.10 (4), p.e0122520-e0122520

2015

Volltextzugriff (PDF)

Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial

British journal of haematology, 2020-09, Vol.190 (6), p.916-922

2020

Volltextzugriff (PDF)

Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns

Journal of thrombosis and haemostasis, 2020-06, Vol.18 (6), p.1390-1397

2020

Volltextzugriff (PDF)

Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data

Clinical chemistry and laboratory medicine, 2020-11, Vol.58 (11), p.1921-1930

2020

Volltextzugriff (PDF)

Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

Pharmacoepidemiology and drug safety, 2021-08, Vol.30 (8), p.1027-1036

2021

Volltextzugriff (PDF)

Multi‐dose drug dispensing as a tool to improve medication adherence: A study in patients using vitamin K antagonists

Pharmacoepidemiology and drug safety, 2018-01, Vol.27 (1), p.46-51

2018

Volltextzugriff (PDF)

Effect of multidose drug dispensing on the time in therapeutic range in patients using vitamin‐K antagonists: A randomized controlled trial

Journal of thrombosis and haemostasis, 2020-01, Vol.18 (1), p.70-78

2020

Volltextzugriff (PDF)

Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data

European heart journal, 2011-08, Vol.32 (15), p.1909-1917

2011

Volltextzugriff (PDF)

Vitamin K therapy to reduce bleeding

Blood, 2020-08, Vol.136 (7), p.780-782

2020

Volltextzugriff (PDF)

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

Research and practice in thrombosis and haemostasis, 2020-01, Vol.4 (1), p.141-153

2020

Volltextzugriff (PDF)

Dosing of factor VIII concentrate by ideal body weight is more accurate in overweight and obese haemophilia A patients

British journal of clinical pharmacology, 2021-06, Vol.87 (6), p.2602-2613

2021

Volltextzugriff (PDF)

Cohort Study on the Management of Cancer-Associated Venous Thromboembolism Aimed at the Safety of Stopping Anticoagulant Therapy in Patients Cured of Cancer

Chest, 2016-05, Vol.149 (5), p.1245-1251

2016

Volltextzugriff (PDF)

Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists

PloS one, 2016-12, Vol.11 (12), p.e0164485-e0164485

2016

Volltextzugriff (PDF)

The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists

Thrombosis and haemostasis, 2022-03, Vol.122 (3), p.377-385

2022

Volltextzugriff (PDF)

Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial

Journal of thrombosis and haemostasis, 2019-02, Vol.17 (2), p.319-328

2019

Volltextzugriff (PDF)

Validation of a perioperative population factor VIII pharmacokinetic model with a large cohort of pediatric hemophilia a patients

British journal of clinical pharmacology, 2021-11, Vol.87 (11), p.4408-4420

2021

Volltextzugriff (PDF)

Accuracy assessment of consecutive test strip lots for whole blood INR point-of-care instruments: clarifying the role of frozen plasma pools

Clinical chemistry and laboratory medicine, 2019-09, Vol.57 (9), p.1349-1357

2019

Volltextzugriff (PDF)

Perioperative Management in Patients Using Vitamin K Antagonists: Observational Cohort Study

Thrombosis and haemostasis, 2020-03, Vol.120 (3), p.495-504

2020

Volltextzugriff (PDF)

Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants

Research and practice in thrombosis and haemostasis, 2020-05, Vol.4 (4), p.586-593

2020

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Englisch
(157)
Niederländisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(123)
Life Sciences & Biomedicine
(117)
Humans
(108)
Male
(68)
Female
(66)
Hematology
(59)
Middle Aged
(58)
Biological And Medical Sciences
(57)
Medical Sciences
(55)
Aged
(52)
Cardiovascular System & Cardiology
(50)
Peripheral Vascular Disease
(42)
Adult
(38)
International Normalized Ratio
(37)
Anticoagulants - Administration & Dosage
(32)
Aged, 80 And Over
(31)
Anticoagulants
(26)
Risk Factors
(26)
Anticoagulants - Therapeutic Use
(25)
Administration, Oral
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study

A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon

Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case‐cohort

Association of VKORC1 polymorphisms and major bleedings in patients who are treated with vitamin K antagonists

Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism

Switching from vitamin K antagonists to direct oral anticoagulants in non‐valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?

The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment

Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial

Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns

Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data

Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

Multi‐dose drug dispensing as a tool to improve medication adherence: A study in patients using vitamin K antagonists

Effect of multidose drug dispensing on the time in therapeutic range in patients using vitamin‐K antagonists: A randomized controlled trial

Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data

Vitamin K therapy to reduce bleeding

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

Dosing of factor VIII concentrate by ideal body weight is more accurate in overweight and obese haemophilia A patients

Cohort Study on the Management of Cancer-Associated Venous Thromboembolism Aimed at the Safety of Stopping Anticoagulant Therapy in Patients Cured of Cancer

Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists

The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists

Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial

Validation of a perioperative population factor VIII pharmacokinetic model with a large cohort of pediatric hemophilia a patients

Accuracy assessment of consecutive test strip lots for whole blood INR point-of-care instruments: clarifying the role of frozen plasma pools

Perioperative Management in Patients Using Vitamin K Antagonists: Observational Cohort Study

Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants

Suchergebnisse filtern